COMPANY PROFILE

Carthera

A clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders

Lyon, FranceFounded 2010Health Tech & Medtech

Valuation $100–250M Last recorded · 2023

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Carthera

Operator of a clinical-stage medtech company intended to develop ultrasound-based medical devices designed to treat brain disorders. The company's devices are intracranial ultrasound implant that temporarily opens the blood-brain barrier and makes way for a significantly increased concentration of therapeutic molecules to reach the brain, enabling doctors and medical professionals with therapeutic devices to diagnose and treat brain complications.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2010
Headquarters: Lyon, France
Employees: 34
Open positions: 1
Dealroom signal: 74.6/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Oncology, Neurology, Spinout, EIC, EIC Fund, Innovation Projects (EIT Health), Innovation Projects 2020 (EIT Health), EIT Health
Technology: Hardware, Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Dec 2023	$5M	$206M	Unorthodox ventures · Supernova Invest · Saint Genys · Bouscas Med	↗
SERIES BOther financing	Jun 2023	$41M	$165M	Panakès Partners · Supernova Invest · Relyens · EIC Fund	↗

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	EBITDA	Margin
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Carthera website traffic

Latest recorded traffic for Carthera is 2.9K monthly website visits, up 5700% over the last three months. Carthera's team declined 2.9% over the past year.

Latest monthly visits2.9K 3-month web change+5700% 1-year team growth-2.9%

Monthly website visitsJan 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NENEURINNOVFocuses on designing, developing and commercializing Active Implantable Medical Devices (AIMD)	Montpellier, France	Operational	16	$5.9M	$13M
OROrixhaDeveloping the LV4C (Liquid Ventilation for Cooling) medical device to almost immediately protect the vital organs, in particular the brain and heart	Saint-Cyr-au-Mont-d'Or, France	Operational
LMLattice MedicalLattice Medical develops MATTISSE, a fully degradable 3D printed breast implant for natural, uncomplicated breast restoration	Loos, France	Operational
RORobeautéWe are developing a sub millimetric microrobot that moves in the brain in curved lines (3D) with sub millimetric precision allowing to access complex areas of the brain in multiple locations to gather data and deliver cargos (micro-electrodes, drugs)	Paris, France	Operational
SISmart ImmuneDevelops off-the-shelf allogeneic T-cell progenitor therapies to restore a fully functional immune system in patients with cancer and severe infections	Paris, France	Operational
EVEverZomA key asset to the future health of an ageing population	Paris, France	Operational
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
OMOMINIOmini develops biosensing devices for immediate blood tests at the patient bedside	Paris, France	Operational